Related Experiment Video
Updated: May 6, 2026

Murine Prostate Micro-dissection and Surgical Castration
Published on: May 11, 2016
Surgical stress delays prostate involution in mice.
Sazzad Hassan1, Yelena Karpova, Anabel Flores
1Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States of America.
Surgical stress delays prostate involution caused by androgen deprivation therapy. This delay is mediated by the beta2-adrenoreceptor/BAD pathway, suggesting beta2-adrenoreceptor antagonists may improve therapy efficacy.
Area of Science:
- Urology
- Endocrinology
- Cell Biology
Background:
- Androgens are crucial for prostate epithelial cell growth.
- Androgen deprivation triggers apoptosis and prostate involution.
- The impact of surgical stress on this process is not well understood.
Purpose of the Study:
- To investigate how surgical stress affects prostate involution induced by androgen ablation.
- To elucidate the underlying molecular mechanisms of this interaction.
Main Methods:
- Androgen ablation was induced in mice via surgical castration and anti-androgenic drugs.
- Surgical stress was simulated using sham castration under anesthesia.
- The role of the beta2-adrenoreceptor/BAD pathway was assessed using specific antagonists and mutant mice.
Main Results:
- Surgical stress significantly delayed apoptosis and prostate involution.
- These stress-induced delays were reversed by a beta2-adrenoreceptor antagonist (ICI118,551).
- The effects were also blocked in mice with a phosphorylation-deficient BAD3SA mutant.
Conclusions:
- Surgical stress can impede androgen ablation therapy by delaying apoptosis and involution.
- The beta2-adrenoreceptor/BAD signaling pathway mediates this delay.
- Beta2-adrenoreceptor antagonists may enhance the efficacy of androgen deprivation therapy.
More Related Videos
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13:37A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies
Published on: March 12, 2014